Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Timing of DNA damage responses impacts persistence to fluoroquinolones.

Mok WWK, Brynildsen MP.

Proc Natl Acad Sci U S A. 2018 Jul 3;115(27):E6301-E6309. doi: 10.1073/pnas.1804218115. Epub 2018 Jun 18.

PMID:
29915065
2.

Biased inheritance protects older bacteria from harm.

Barrett TC, Mok WWK, Brynildsen MP.

Science. 2017 Apr 21;356(6335):247-248. doi: 10.1126/science.aan0348. Epub 2017 Apr 20. No abstract available.

PMID:
28428383
3.

An Orphan Riboswitch Unveils Guanidine Regulation in Bacteria.

Mok WWK, Brynildsen MP.

Mol Cell. 2017 Jan 19;65(2):205-206. doi: 10.1016/j.molcel.2017.01.001.

4.

Non-Monotonic Survival of Staphylococcus aureus with Respect to Ciprofloxacin Concentration Arises from Prophage-Dependent Killing of Persisters.

Sandvik EL, Fazen CH, Henry TC, Mok WW, Brynildsen MP.

Pharmaceuticals (Basel). 2015 Nov 17;8(4):778-92. doi: 10.3390/ph8040778.

5.

RNA Futile Cycling in Model Persisters Derived from MazF Accumulation.

Mok WW, Park JO, Rabinowitz JD, Brynildsen MP.

MBio. 2015 Nov 17;6(6):e01588-15. doi: 10.1128/mBio.01588-15.

6.

Effectiveness of a discharge planning and community support programme in preventing readmission of high-risk older patients.

Lin FO, Luk JK, Chan TC, Mok WW, Chan FH.

Hong Kong Med J. 2015 Jun;21(3):208-16. doi: 10.12809/hkmj144304. Epub 2015 Apr 9.

7.

Impacts of global transcriptional regulators on persister metabolism.

Mok WW, Orman MA, Brynildsen MP.

Antimicrob Agents Chemother. 2015 May;59(5):2713-9. doi: 10.1128/AAC.04908-14. Epub 2015 Feb 23.

8.

Aminoglycoside-enabled elucidation of bacterial persister metabolism.

Orman MA, Mok WW, Brynildsen MP.

Curr Protoc Microbiol. 2015 Feb 2;36:17.9.1-14. doi: 10.1002/9780471729259.mc1709s36.

9.

A hidden cause of recurrent asthmatic attacks.

Shea YF, Mok WW, Chan JF, Kwan JS.

J Am Geriatr Soc. 2014 Jul;62(7):1408-9. doi: 10.1111/jgs.12901. No abstract available.

PMID:
25039524
10.

The role of metabolism in bacterial persistence.

Amato SM, Fazen CH, Henry TC, Mok WW, Orman MA, Sandvik EL, Volzing KG, Brynildsen MP.

Front Microbiol. 2014 Mar 3;5:70. doi: 10.3389/fmicb.2014.00070. eCollection 2014. Review.

11.

Therapeutic peptides: new arsenal against drug resistant pathogens.

Mok WW, Li Y.

Curr Pharm Des. 2014;20(5):771-92. Review.

PMID:
23688084
12.

A highly efficient molecular cloning platform that utilises a small bacterial toxin gene.

Mok WW, Li Y.

Chembiochem. 2013 Apr 15;14(6):733-8. doi: 10.1002/cbic.201300033. Epub 2013 Mar 19.

PMID:
23512843
13.

Developing fluorogenic RNA-cleaving DNAzymes for biosensing applications.

Ali MM, Aguirre SD, Mok WW, Li Y.

Methods Mol Biol. 2012;848:395-418. doi: 10.1007/978-1-61779-545-9_25.

PMID:
22315083
14.

Decoding toxicity: deducing the sequence requirements of IbsC, a type I toxin in Escherichia coli.

Mok WW, Patel NH, Li Y.

J Biol Chem. 2010 Dec 31;285(53):41627-36. doi: 10.1074/jbc.M110.149179. Epub 2010 Oct 27.

15.

Characterization of an RNA-cleaving deoxyribozyme with optimal activity at pH 5.

Kandadai SA, Mok WW, Ali MM, Li Y.

Biochemistry. 2009 Aug 11;48(31):7383-91. doi: 10.1021/bi900631u.

PMID:
19583262
16.

Identification of a toxic peptide through bidirectional expression of small RNAs.

Mok WW, Navani NK, Barker C, Sawchyn BL, Gu J, Pathania R, Zhu RD, Brown ED, Li Y.

Chembiochem. 2009 Jan 26;10(2):238-41. doi: 10.1002/cbic.200800591. No abstract available.

PMID:
19090519

Supplemental Content

Support Center